奥曲肽在不可切除胆管癌姑息治疗中的应用：对疾病稳定有效吗？ - Suppr

Suppr

超能文献

Octreotide in Palliative Treatment of Unresectable Cholangiocarcinoma: Is it Effective for Disease Stabilization?

作者信息

Pistevou-Gompaki Kiki, Eleftheriadis Nikos, Papaloukas Christos, Eleftheriadis Damianos

机构信息

Department of Radiation Oncology, Aristotle's University of Thessaloniki, Greece.

出版信息

Clin Med Oncol. 2008;2:367-9. doi: 10.4137/cmo.s677. Epub 2008 Apr 24.

DOI:10.4137/cmo.s677

PMID:21892300

原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3161628/

Abstract

摘要

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7e75/3161628/ceb073e36b71/cmo-2-2008-367f1.jpg

相似文献

Octreotide in Palliative Treatment of Unresectable Cholangiocarcinoma: Is it Effective for Disease Stabilization?奥曲肽在不可切除胆管癌姑息治疗中的应用：对疾病稳定有效吗？

Clin Med Oncol. 2008;2:367-9. doi: 10.4137/cmo.s677. Epub 2008 Apr 24.

Impact of intraoperative radiotherapy (IORT) on survival of patients with unresectable hilar cholangiocarcinoma.术中放疗（IORT）对不可切除肝门部胆管癌患者生存率的影响。

Hepatogastroenterology. 2008 Nov-Dec;55(88):1951-4.

Octreotide in Palliative Treatment of Hepatic Metastases: Is it Effective for Clinical Stabilization?奥曲肽在肝转移瘤姑息治疗中的应用：对临床病情稳定是否有效？

Clin Med Oncol. 2008;2:401-3. doi: 10.4137/cmo.s409. Epub 2008 May 13.

Klatskin tumor presenting as unresectable perihilar hepatic mass: A case report.表现为不可切除的肝门周围肝脏肿块的肝门部胆管癌：病例报告

Radiol Case Rep. 2021 Jul 5;16(9):2537-2541. doi: 10.1016/j.radcr.2021.06.027. eCollection 2021 Sep.

Everolimus plus octreotide long-acting repeatable for the treatment of advanced neuroendocrine tumours associated with carcinoid syndrome (RADIANT-2): a randomised, placebo-controlled, phase 3 study.依维莫司联合奥曲肽长效缓释剂治疗与类癌综合征相关的晚期神经内分泌肿瘤（RADIANT-2）：一项随机、安慰剂对照、3 期研究。

Lancet. 2011 Dec 10;378(9808):2005-2012. doi: 10.1016/S0140-6736(11)61742-X. Epub 2011 Nov 25.

Entering the third decade of experience with octreotide LAR in neuroendocrine tumors: A review of current knowledge.进入使用长效奥曲肽治疗神经内分泌肿瘤的第三个十年经验：当前知识综述

Tumori. 2019 Apr;105(2):113-120. doi: 10.1177/0300891618765362. Epub 2018 Apr 6.

Transcatheter arterial chemoembolization in unresectable cholangiocarcinoma: initial experience in a single institution.不可切除胆管癌的经导管动脉化疗栓塞术：单机构的初步经验

J Vasc Interv Radiol. 2005 Mar;16(3):353-61. doi: 10.1097/01.RVI.0000143768.60751.78.

Octreotide for palliative treatment of hepatic metastases from non-neuroendocrine primary tumours: evaluation of quality of life using the EORTC QLQ-C30 questionnaire.

Palliat Med. 2003 Apr;17(3):257-62. doi: 10.1191/0269216303pm698oa.

[Cholangiocarcinoma].[胆管癌]

Rev Med Chil. 2008 Feb;136(2):240-8. Epub 2008 May 7.

Unresectable hilar cholangiocarcinoma: multimodality approach with percutaneous treatment associated with radiotherapy and chemotherapy.不可切除的肝门部胆管癌：多模态治疗方法，包括经皮治疗联合放疗和化疗。

In Vivo. 2006 Nov-Dec;20(6A):757-60.

本文引用的文献

Endoscopic and surgical therapy for intrahepatic cholangiocarcinoma in the united states: a population-based study.美国肝内胆管癌的内镜及手术治疗：一项基于人群的研究

J Clin Gastroenterol. 2007 Nov-Dec;41(10):911-7. doi: 10.1097/MCG.0b013e31802f3132.

Octreotide for palliative treatment of hepatic metastases from non-neuroendocrine primary tumours: evaluation of quality of life using the EORTC QLQ-C30 questionnaire.

Palliat Med. 2003 Apr;17(3):257-62. doi: 10.1191/0269216303pm698oa.

Cholangiocarcinoma cells express somatostatin receptor subtype 2 and respond to octreotide treatment.胆管癌细胞表达生长抑素受体亚型2，并对奥曲肽治疗有反应。

J Hepatobiliary Pancreat Surg. 2002;9(4):497-502. doi: 10.1007/s005340200062.

Is octreotide useful for hepatic metastases due to non-neuroendocrine primary tumors?奥曲肽对非神经内分泌原发性肿瘤所致肝转移是否有效？

Clin Oncol (R Coll Radiol). 2002 Aug;14(4):330-1. doi: 10.1053/clon.2002.0084.

Long-acting depot lanreotide in the treatment of patients with advanced neuroendocrine tumors.长效缓释兰瑞肽治疗晚期神经内分泌肿瘤患者

Am J Clin Oncol. 2000 Aug;23(4):412-5. doi: 10.1097/00000421-200008000-00020.

Somatostatin and hepatocellular carcinoma.生长抑素与肝细胞癌

Gastroenterology. 1998 Nov;115(5):1298-9. doi: 10.1016/s0016-5085(98)70109-x.

Treatment of hepatocellular carcinoma with octreotide: a randomised controlled study.用奥曲肽治疗肝细胞癌：一项随机对照研究。

Gut. 1998 Mar;42(3):442-7. doi: 10.1136/gut.42.3.442.

High-dose treatment with lanreotide of patients with advanced neuroendocrine gastrointestinal tumors: clinical and biological effects.高剂量兰瑞肽治疗晚期胃肠神经内分泌肿瘤患者：临床及生物学效应

Ann Oncol. 1997 Oct;8(10):1041-4. doi: 10.1023/a:1008205415035.

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验